MVP and breast carcinoma: Finally, adipocytes confer a multidrug resistance phenotype to breast cancer cells by increasing the nuclear efflux of Doxorubicin (DOX) through a major vault protein (MVP)-dependent process and its expulsion from breast cancer cells via EVs (88).